Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2026-04-14 @ 9:14 PM
Study NCT ID:
NCT06054906
Status:
RECRUITING
Last Update Posted:
2024-12-30
First Post:
2023-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
Sponsor:
Huashan Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KY2022-1018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None